Intervenção Digital para o Tratamento da Insónia em Sobreviventes de Cancro: Protocolo de um Ensaio Clínico Pragmático
DOI:
https://doi.org/10.20344/amp.21094Palavras-chave:
Distúrbios do Início e da Manutenção do Sono, Neoplasias/complicações, Saúde Digital, Terapia Cognitivo-ComportamentalResumo
Introdução: A insónia é um dos sintomas associados ao cancro mais prevalentes, persistentes e debilitantes, afetando quase metade das pessoas sobreviventes. Embora a terapia cognitivo-comportamental para a insónia esteja bem estabelecida como o tratamento de referência para a insónia persistente, permanece praticamente inacessível na prática clínica. Pretendemos examinar os efeitos clínicos e a aceitabilidade de uma intervenção digital de terapia cognitivo-comportamental para a insónia para pessoas sobreviventes de cancro com sintomas de insónia através de um ensaio clínico em Portugal.
Métodos e Análise: O nosso ensaio oncológico vai testar os efeitos clínicos e aceitabilidade de uma intervenção digital de terapia cognitivo-comportamental para a insónia com apoio clínico oferecido online, o programa OncoSleep. O programa online inclui seis sessões semanais, interativas e personalizadas, que envolvem técnicas baseadas na evidência para reduzir a hiperativação psicofisiológica e condicionamentos maladaptativos, adaptadas à sobrevivência oncológica. O recrutamento será realizado na população geral e, após triagem, os participantes elegíveis serão aleatoriamente alocados a um de dois braços: o grupo de intervenção da terapia cognitivo-comportamental para a insónia ou um grupo em lista de espera. A gravidade da insónia (indicador primário), fadiga, indicadores de sono, sofrimento psicológico, e a qualidade de vida (indicadores secundários) serão avaliados pré- e pós-intervenção.
Downloads
Referências
World Cancer Research Fund International. Cancer survival statistics. 2022. [cited 2023 Dec 20]. Available from: https://www.wcrf.org/cancer-trends/cancer-survival-statistics/.
American Association for Cancer Research. Cancer progress report. 2022. [cited 2023 Dec 20]. Available from: https://cancerprogressreport.aacr.org/progress/.
Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656-73.
Reynolds-Cowie P, Fleming L. Living with persistent insomnia after cancer: a qualitative analysis of impact and management. Br J Health Psychol. 2021;26:33-49.
Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, et al. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010;28:292-8.
Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19:895-908.
Lis CG, Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer. 2008;16:261-6.
Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, et al. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night. J Pineal Res. 2011;51:259-69.
Innominato PF, Spiegel D, Ulusakarya A, Giacchetti S, Bjarnason GA, Lévi F, et al. Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer. Sleep Med. 2015;16:391-8.
Marinac CR, Nelson SH, Flatt SW, Natarajan L, Pierce JP, Patterson RE. Sleep duration and breast cancer prognosis: perspectives from the women’s healthy eating and living study. Breast Cancer Res Treat. 2017;162:581-9.
Trudel-Fitzgerald C, Zhou ES, Poole EM, Zhang X, Michels KB, Eliassen AH. Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study. Br J Cancer. 2017;116:1239-46.
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD, Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165:125-33.
Riemann D, Espie CA, Altena E, Arnardottir ES, Baglioni C, Bassetti CL, et al. The European Insomnia Guideline: an update on the diagnosis and treatment of insomnia 2023. J Sleep Res. 2023;32:e14035.
Squires LR, Rash JA, Fawcett J, Garland SN. Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivors. Sleep Med Rev. 2022;63:101615.
Denis D, Eley TC, Rijsdijk F, Zavos HM, Keers R, Espie CA, et al. Is digital cognitive behavioural therapy for insomnia effective in treating sub-threshold insomnia: a pilot RCT. Sleep Med. 202;66:174-83.
Clara MI, Canavarro MC, Miller-Mendes M, Allen Gomes A. Insomnia in cancer survivors: a precision behavioral sleep medicine approach. Eur Psychol. 2023;28:2.
Garland SN. A step in the right direction: making cognitive-behavioral therapy for insomnia more accessible to people diagnosed with cancer. Sleep. 2021;44:zsab202.
National Cancer Institute. Sleep disorders. 2022. [cited 2023 Dec 20]. Available from: https://www.cancer.gov/about-cancer/treatment/side-effects/sleepdisorders-hp-pdq.
European Cancer Organisation. Time to accelerate: together against cancer. 2023. [cited 2023 Dec 20]. Available from: https://www.europeancancer.org/manifesto.
Grassi L, Zachariae R, Caruso R, Palagini L, Campos-Ródenas R, Riba MB, et al. Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline. ESMO Open. 2023;8:102047.
Morin CM, Belleville G, Bélanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601-8.
Clemente V, Ruivo Marques D, Miller-Mendes M, Morin CM, Serra J, Allen Gomes A. The European Portuguese version of the insomnia severity index. J Sleep Res. 2021;30:e13198.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-70.
Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychol Health Med. 2007;12:225-35.
Seligman ME. The effectiveness of psychotherapy: The consumer reports study. Am Psychol. 1995;50:12.
Vaz Serra A., Canavarro MC, Simões MR, Pereira M, Gameiro S, Quartilho ML, et al. Estudos psicométricos do instrumento de avaliação da qualidade de vida da Organização Mundial de Saúde (WHOQOL-Bref) para Português de Portugal. Psiq Clín. 2006;27:41.
The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998;28:551-8.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
Pais-Ribeiro JL, Pinto C, Santos C. Validation study of the Portuguese version of the QLC-C30- V3. Psicol Saúde Doenças. 2008;9:89-102.
Stein KD, Jacobsen PB, Blanchard CM, Thors C. Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage. 2004;27:14-23.
Clara MI, Stein K, Canavarro MC, Allen Gomes A. European Portuguese version of the multidimensional fatigue symptom inventory-short form: validation study. Acta Med Port. 2023;36:723-30.
Morin CM, Espie CA. Insomnia: a clinical guide to assessment and treatment. New York: Springer; 2013.
Clara MI, Canavarro MC, Severina A, Ramos S, Rafael C, Allen Gomes A. Assessment of cancer-related fatigue expression: comparing the expression of fatigue in patients with a history of cancer, patients with other chronic diseases, and healthy individuals. Psycho-Oncologie. 2024;18:49-57.
Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13:e126.
Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601-8.
Savard J, Ivers H, Savard MH, Morin CM. Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep. 2014;37:1305-14.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200-7.
van Straten A, Cuijpers P. Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev. 2009;13:61-71.
Ho FY, Chung KF, Yeung WF, Ng TH, Cheng SK. Weekly brief phone support in self-help cognitive behavioral therapy for insomnia disorder: relevance to adherence and efficacy. Behav Res Ther. 2014;63:147-56.
Kaldo V, Jernelöv S, Blom K, Ljótsson B, Brodin M, Jörgensen M, et al. Guided internet cognitive behavioral therapy for insomnia compared to a control treatment - a randomized trial. Behav Res Ther. 2015;71:90-100.
Savard J, Ivers H, Savard MH, Morin CM. Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep. 2014;37:1305-14.
Hasan F, Tu YK, Yang CM, James Gordon C, Wu D, Lee HC, et al. Comparative efficacy of digital cognitive behavioral therapy for insomnia: a systematic review and network meta-analysis. Sleep Med Rev. 2022;61:101567.
Gao Y, Ge L, Liu M, Niu M, Chen Y, Sun Y, et al. Comparative efficacy and acceptability of cognitive behavioral therapy delivery formats for insomnia in adults: a systematic review and network meta-analysis. Sleep Med Rev. 2022;64:101648.
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2024 Acta Médica Portuguesa
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
Este trabalho encontra-se publicado com a Creative Commons Atribuição-NãoComercial 4.0.
Todos os artigos publicados na AMP são de acesso aberto e cumprem os requisitos das agências de financiamento ou instituições académicas. Relativamente à utilização por terceiros a AMP rege-se pelos termos da licença Creative Commons ‘Atribuição – Uso Não-Comercial – (CC-BY-NC)’.
É da responsabilidade do autor obter permissão para reproduzir figuras, tabelas, etc., de outras publicações. Após a aceitação de um artigo, os autores serão convidados a preencher uma “Declaração de Responsabilidade Autoral e Partilha de Direitos de Autor “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) e a “Declaração de Potenciais Conflitos de Interesse” (http://www.icmje.org/conflicts-of-interest) do ICMJE. Será enviado um e-mail ao autor correspondente, confirmando a receção do manuscrito.
Após a publicação, os autores ficam autorizados a disponibilizar os seus artigos em repositórios das suas instituições de origem, desde que mencionem sempre onde foram publicados e de acordo com a licença Creative Commons